iPS-derived MSCs from an expandable bank to deliver a prodrug-converting enzyme that limits growth and metastases of human breast cancers

Mostrar otras versiones (1)
Detalles Bibliográficos
Autores principales: Ullah, M, Kuroda, Y, Bartosh, T J, Liu, F, Zhao, Q, Gregory, C, Reger, R, Xu, J, Lee, R H, Prockop, D J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5563522/
https://www.ncbi.nlm.nih.gov/pubmed/28845293
http://dx.doi.org/10.1038/cddiscovery.2017.29

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5563522/
https://www.ncbi.nlm.nih.gov/pubmed/28845293
http://dx.doi.org/10.1038/cddiscovery.2017.29

Ejemplares similares